Home » Doctors » Medicare » Currently Reading:

House Health-Care Bill: AMA! Obama! Protesters!

November 7, 2009 Doctors, Medicare No Comments

By Jacob Goldstein

House Health-Care Bill: AMA! Obama! Protesters!Sorry about all those exclamation marks in the headline. But there’s lots of action in DC today, what with the House set to vote on the big health-care bill this Saturday.

The AMA came out in favor of the House bill today. Not a huge surprise, given the group’s endorsement of the health-care bill introduced in the House earlier this year. Still, the new version of the legislation splits a provision about Medicare payments to doctors — a $250 billion provision dear to the AMA’s heart — into a separate bill. The AMA’s president called for the two bills to be passed together. The AARP backed the two bills as well.

President Obama made a cameo appearance at a routine press briefing to tout the endorsements. He said he was “extraordinarily pleased and grateful” for the organizations’ backing, Politico reports. “Remember this endorsement the next time you see a bunch of misleading ads on television,” he said. Obama plans to go to the House tomorrow to try to sway Reps who are on the fence, the WSJ says.

Meanwhile, thousands of protesters gathered outside the Capitol this afternoon chanting “kill the bill,” the New York Times reports. They gathered for a rally organized by Rep. Michele Bachmann, a Republican from Minnesota.

Bonus Bill: WashWire tells you what to keep an eye on in the big vote on Saturday.

Photo: Associated Press

Comment on this Article:







Partner links

Advertising

Drugs

South Korean FDA Probes Roche for Aiding Tamiflu Stockpiling

November 8, 2009

By Shirley S. Wang
Should companies be allowed to buy large quantities of medicine like Tamiflu to have on hand in case their employees develop the H1N1 flu virus? Not according to the law in South Korea, where it’s illegal for non-medical professionals to purchase big lots of drugs. Punishment is up to five years in [...]

Boosting Medical Students’ Training in Drug Abuse

November 7, 2009

By Shirley S. Wang
There’s lot of action these days aimed at curbing the abuse of prescription drugs. The FDA is working on a plan to make it harder for people to get access to unauthorized prescription painkillers, pain specialists have come out with guidelines to help doctors manage pain-drug-abusing patients and drug companies have been [...]

What Will Pfizer’s R&D Look Like a Year from Now?

October 21, 2009

By Jonathan D. Rockoff
Pfizer’s huge R&D shop is even bigger now that the company has swallowed Wyeth. To get a sense of the changes that could be in store, the Health Blog spoke today with the company’s two top R&D execs — Martin Mackay, a Pfizer veteran who will lead small-molecule work, and Mikael Dolsten, [...]

See Your Doctor: The Dawn of Consumer Drug Ads

October 13, 2009

By Jacob Goldstein
For a look back at a key breakthrough in the history of the pharmaceutical industry, we turn now to Joe Davis, a retired ad guy who lives in Vermont.
Back in the mid-1980s, Davis came up with an idea: Run a TV ad for Seldane, the allergy medicine, but don’t say the drug’s name. [...]

Why Other Drugmakers Want to Be More Like J&J

October 12, 2009

By Jacob Goldstein
Johnson & Johnson’s third-quarter earnings, out today, provide the latest reminder of why other drugmakers want to be more like J&J.
In a nutshell: It’s a tough time to be in the prescription drug business, what with stiff competition from generics manufacturers and payers pushing for lower costs on branded drugs. So it’s nice [...]

Related Links

Research

What Will Pfizer’s R&D Look Like a Year from Now?

October 21, 2009

By Jonathan D. Rockoff
Pfizer’s huge R&D shop is even bigger now that the company has swallowed Wyeth. To get a sense of the changes that could be in store, the Health Blog spoke today with the company’s two top R&D execs — Martin Mackay, a Pfizer veteran who will lead small-molecule work, and Mikael Dolsten, [...]

Are Mammograms and PSA Tests Overrated?

October 21, 2009

By Jacob Goldstein
Catch cancers early and treat them before they become deadly. That’s the idea behind cancer screening, and that’s clearly how it works with pap smears for cervical cancer and colonoscopy for colon cancer.
But in some cases screening can lead to aggressive treatment of slow-growing tumors that would never have caused a problem [...]

The Problem With Ranking Countries’ Health-Care Systems

October 20, 2009

By Jacob Goldstein
The oft-cited WHO ranking that said the U.S. has the 37th best health-care system in the world is dated and had problems even when it was new, WSJ stats maven Carl Bialik writes in his column today.
The ranking was published in 2000, and came up against a major problem: Good data weren’t available [...]